ORLANDO, Fla., Dec. 02, 2015 (GLOBE NEWSWIRE) -- CNL Financial Group’s Head of Regulatory Affairs Kirk Montgomery will speak at IMN’s Western Non-Traded REIT & Retail Alternative Investment Symposium, held Dec 2-3 in Laguna Niguel, Calif.
On Dec. 2, Montgomery will speak on a panel called, “DOL, FINRA, SEC, NASAA: A Practical Understanding of What the Latest Regulatory Developments Mean for Product Sponsors & Broker-Dealers.”
Panelists will discuss how key regulation and legislation will directly impact product sponsors and independent retail broker-dealers and registered investment advisors. Topics will include the Department of Labor’s proposed fiduciary rule, FINRA 15-02, U.S. Securities and Exchange Commission updates and what’s on the horizon for the North American Securities Administrators Association.
“The IMN symposium is a great opportunity to discuss critical issues in our industry,” Montgomery said. “I am honored to be able to represent CNL Financial Group and share my expertise with other professionals from across the country.”
The Investment Management division of IMN produces industry-leading educational and networking forums for institutional investors. Their events cater to index and exchange-traded fund investing, public funds, foundations and endowments, alternative investments, securities lending and distressed investing professionals.
About CNL Financial Group
CNL Financial Group (CNL) is a leading private investment management firm providing global real estate and alternative investments. Since inception in 1973, CNL and/or its affiliates have formed or acquired companies with more than $33 billion in assets. CNL is headquartered in Orlando, Florida. For more information, visit CNL.com.
For information contact: Sherry Magee Senior Vice President Communications CNL Financial Group 407-650-1223


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Washington Post Publisher Will Lewis Steps Down After Layoffs
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



